Results 161 to 170 of about 8,163,121 (296)

Tensor network-based gene regulatory network inference for single-cell transcriptomic data. [PDF]

iScience
Sanz Larrarte O, Aizpurua B, Dastbasteh R, Otxoa RM, Etxezarreta Martinez J.   +4 more
europepmc   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

FGFR3-driven gene regulatory network analysis reveals a protumoral role for p63 in luminal bladder tumors. [PDF]

J Clin Invest
Moreno-Vega A, Zambrano M, Estrada-Virrueta L, Meng X, Puig J, Neyret-Kahn H, Shi M, Dufour F, Gilbert G, Li K, Groeneveld C, Fontugne J, Pérez-Escavy M, Dhifli W, Hua C, Cabel L, Krucker C, Tanguy L, Lindskrog SV, Beraud C, Langle YV, Ye T, Tahi F, Davidson I, Paramio JM, Dyrskjøt L, Allory Y, Lluel P, Eiján AM, Elati M, Radvanyi F, Lodillinsky C, Bernard-Pierrot I.   +32 more
europepmc   +1 more source

ADP‐ribosylation: An emerging regulator of the epigenome

Molecular Oncology, EarlyView.
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho, Chenqian Liu, W. Lee Kraus   +2 more
wiley   +1 more source

Controllability of the gene regulatory network in zebrafish embryogenesis. [PDF]

Sci Rep
Park J, Cho K, Lee J, Kim J.
europepmc   +1 more source

Castration‐resistant prostate cancer cells are addicted to the high activity of cyclin‐dependent kinase 2

Molecular Oncology, EarlyView.
We show that emergence of castration‐resistant prostate (CRPC) is associated with significant upregulation of cyclins that positively regulate cyclin‐dependent kinase 2 (CDK2) and concomitant downregulation of CDK4 cyclins. This renders CRPC cells dependent on the high activity of CDK2, and CDK2 inhibitors synergistically sensitize CRPC cells to both ...
Joyeeta Chatterjee, Alessia Marin, Shivani Yalala, Harri M. Itkonen   +3 more
wiley   +1 more source

GRNFormer: accurate gene regulatory network inference using graph transformer. [PDF]

Bioinformatics
Hegde A, Cheng J.
europepmc   +1 more source

Unraveling the epigenetic code in cancer cell–tumor microenvironment crosstalk

Molecular Oncology, EarlyView.
Epigenetic regulation is a key driver of cancer development and progression. Diverse epigenetic alterations in cancer cells and components of the tumor microenvironment (TME) orchestrate their communication through multiple mechanisms. We discuss how the epigenetic code coordinates bidirectional cancer cell–TME crosstalk to promote cancer progression ...
Ji Hoon Park, Mi‐Young Kim
wiley   +1 more source

Differential gene regulatory network analysis reveals transcriptional disruption in opioid. [PDF]

NAR Genom Bioinform
Ren J, Wang X, Luan F, Chen Y, Gao L, Ho W, Wei Z.   +6 more
europepmc   +1 more source

Arginine methylation as a regulatory ratchet in cancer: From substrate selection to malignant‐state stabilization

Molecular Oncology, EarlyView.
Arginine methylation can be viewed as a persistence‐prone post‐translational modification regulated by a network of PRMTs. Competitive and compensatory interactions among PRMTs can redistribute methylation across substrate pools shaped by sequence, structural, spatial, and environmental layers, reinforcing RNA‐processing, chromatin, and signaling ...
So Hyun Kwon, Ji Min Lee
wiley   +1 more source